Inicio › Linfoma difuso de células B grandes › Tennessee › Nashville
Ensayos clínicos de Linfoma difuso de células B grandes en Nashville, TN
17 estudios para Linfoma difuso de células B grandes buscan participantes en centros de Nashville y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
ReclutandoFase 1/2
- SCRI Oncology Partners ( Site 0100), Nashville
- Henry-Joyce Cancer Clinic ( Site 0115), Nashville
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
ReclutandoFase 3
- SCRI Oncology Partners ( Site 7000), Nashville
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
ReclutandoFase 2
- SCRI Oncology Partners ( Site 7002), Nashville
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
ReclutandoFase 2
- Tennessee Oncology, Nashville
A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies
ReclutandoFase 1/2
- Sarah Cannon Research Institute, Nashville
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
ReclutandoFase 1
- SCRI Oncology Partners, Nashville
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
ReclutandoFase 3
- SCRI Oncology Partners, Nashville
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
ReclutandoFase 1
- Sarah Cannon Research Institute, Nashville
- Vanderbilt University Medical Center, Nashville
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
ReclutandoFase 2
- Vanderbilt University Medical Center, Nashville
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
ReclutandoFase 1/2
- TriStar BMT, Nashville
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
ReclutandoFase 1
- Scri Oncology Partners, Nashville
- Vanderbilt Medical Center, Nashville
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
ReclutandoFase 1/2
- Tennessee Oncology, Pllc Nashville, Nashville
Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma
ReclutandoFase 2
- Vanderbilt University/Ingram Cancer Center, Nashville
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
ReclutandoFase 1/2
- Sarah Cannon Research Institute, Nashville
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
ReclutandoFase 1/2
- Vanderbilt University Medical Center, Nashville
DALY II USA/ MB-CART2019.1 for DLBCL
ReclutandoFase 2
- SCRI Oncology Partners, Nashville
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
ReclutandoFase 1
- Tennessee Oncology, Nashville
Ensayos de Linfoma difuso de células B grandes en otras ciudades
- New York City, NY20 estudios
- Baldwin Park, CA19 estudios
- Los Angeles, CA18 estudios
- Houston, TX18 estudios
- Chicago, IL18 estudios
- Milwaukee, WI17 estudios
- Boston, MA17 estudios
- Philadelphia, PA15 estudios
- Durham, NC15 estudios
- Portland, OR15 estudios
- Cleveland, OH13 estudios
- Seattle, WA13 estudios
Otros estudios en Nashville
- Cáncer de pulmón de células no pequeñas97 estudios
- Cáncer de seno78 estudios
- Cáncer metastásico69 estudios
- Cáncer del colon y del recto67 estudios
- Cáncer (todos los tipos)65 estudios
- Cáncer de ovario50 estudios
- Carcinoma de células escamosas de cabeza y cuello43 estudios
- Cáncer de próstata40 estudios
- Cáncer de páncreas39 estudios
- Cáncer de pulmón39 estudios
- Cáncer de endometrio38 estudios
- Melanoma34 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.